Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts Pharmaceutical Investing
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression Life Science Investing News
Cizzle Brands Corporation Reports $5.64 Million in Net Sales in the First Half of its 2025 Fiscal Year Company News
ELAHERE® Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients Pharmaceutical Investing
UPLIZNA® SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS Life Science Investing News